Onclive articles Copyright (c) 2014 Intellisphere, LLC. All rights reserved. http://www.onclive.com/articles Onclive articles Onclive articles en-us Thu, 27 Nov 2014 21:52:13 EST 5 Onclive articles 144 47 http://www.onclive.com/articles http://www.onclive.com/media/image/35ab4bcc0544887940a968b55494cbb1.jpg <![CDATA[Becoming a Champion of Change:Educating Fellows on the Costs of Cancer Care]]>http://www.onclive.com/publications/oncology-fellows/2014/september-2014/Becoming-a-Champion-of-ChangeEducating-Fellows-on-the-Costs-of-Cancer-CareOnclive articlesusThu, 27 Nov 2014 08:04:01 ESTOnclive<![CDATA[PARP Inhibitors for Breast and Ovarian Cancers]]>http://www.onclive.com/publications/contemporary-oncology/2014/November-2014/PARP-Inhibitors-for-Breast-and-Ovarian-CancersOnclive articlesusWed, 26 Nov 2014 16:02:01 ESTOnclive<![CDATA[Anderson Provides Insight Into Novel Agents in Multiple Myeloma]]>http://www.onclive.com/web-exclusives/Anderson-Examines-Novel-Agents-in-Multiple-MyelomaOnclive articlesusWed, 26 Nov 2014 08:02:01 ESTOnclive<![CDATA[To Succeed, Urology Practices Must Change With the Times]]>http://www.onclive.com/web-exclusives/To-Succeed-Urology-Practices-Must-Change-With-the-TimesOnclive articlesusTue, 25 Nov 2014 12:01:01 ESTOnclive<![CDATA[FDA Extends Panobinostat Review Period for Multiple Myeloma]]>http://www.onclive.com/web-exclusives/FDA-Extends-Panobinostat-Review-Period-for-Multiple-MyelomaOnclive articlesusTue, 25 Nov 2014 10:44:22 ESTOnclive<![CDATA[Government Come to Call? How to Protect Your Practice]]>http://www.onclive.com/web-exclusives/Government-Come-to-Call-How-to-Protect-Your-PracticeOnclive articlesusTue, 25 Nov 2014 09:26:23 ESTOnclive<![CDATA[Pfizer, Merck KGaA Collaboration Accelerates PD-L1 Inhibitor Development]]>http://www.onclive.com/web-exclusives/Pfizer-Merck-KGaA-Collaboration-Accelerates-PD-L1-Inhibitor-DevelopmentOnclive articlesusMon, 24 Nov 2014 19:27:38 ESTOnclive<![CDATA[Juno CAR T Cell Therapy Receives Breakthrough Designation for ALL]]>http://www.onclive.com/web-exclusives/Juno-CAR-T-Cell-Therapy-Receive-Breakthrough-Designation-for-ALLOnclive articlesusMon, 24 Nov 2014 14:38:48 ESTOnclive<![CDATA[FDA Grants Orphan Drug Designation to BGB324 for AML]]>http://www.onclive.com/web-exclusives/FDA-Grants-Orphan-Drug-Designation-to-BGB324-for-AMLOnclive articlesusMon, 24 Nov 2014 14:13:01 ESTOnclive<![CDATA[Early IDH1 Inhibitor Data Promising in AML]]>http://www.onclive.com/web-exclusives/Early-IDH1-Inhibitor-Data-Promising-in-AMLOnclive articlesusMon, 24 Nov 2014 11:28:30 ESTOnclive